SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Life Science Investing Sixth Wave Announces Extension of SARS-CoV-2 Research Agreement with UofA and Li Ka Shing Institute of Virology
BioHarvest Sciences Inc. Receives Approval from Israel's Ministry of Health to Include VINIA in a Health Snack Bar
Medical Device Investing Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening
Pharmaceutical Investing Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group's Tmall Global, Reaching More Than 750 Million Potential New Consumers
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BELLUS Health Inc. - BLU
Psychedelics Investing SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Champignon Brands Inc. - SHRMF
BLU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 17, 2021 in the Class Action Filed on Behalf of BELLUS Health Inc. Limited Shareholders
